Reuters - Sanofi-Aventis is withdrawing its
application to sell obesity drug rimonabant -- its biggest new
drug hope -- in the United States, dealing a further blow to
its pipeline hopes.
Source: http://rss.news.yahoo.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment